Discovering New Potential in Adult Stem Cells: Therapeutic Solutions International Unlocks Mechanism of Action to Combat COPD

Therapeutic Solutions International (TSOI) has made a groundbreaking discovery that has the potential to revolutionize treatments for Chronic Obstructive Pulmonary Disease (COPD). By studying a specialized type of B cell, the company was able to demonstrate that the therapeutic activity of JadiCell in a model of COPD can be transferred to naïve animals. Not only that, TSOI also uncovered that antibody mediated blockade of the cytokine interleukin-35 was able to block this therapeutic activity. In light of these findings, the company has filed a patent to protect its discovery.

Today’s findings provide new evidence for the clinical effectiveness of JadiCells in treating a wide range of pulmonary conditions, from acute cases like COVID-19 ARDS to chronic degenerative diseases like COPD. By uncovering the important role of interleukin-35 in enhancing the therapeutic effects of these cells, we are closer to improving the already powerful effects they demonstrate. According to Dr. James Veltmeyer, co-inventor and Chief Medical Officer at the Company, this is an exciting step forward.

Therapeutic Solutions International has acquired a patent from JadiCell, LLC (#9,803,176 B2) for respiratory indications, and has several other patent applications in progress and published that cover the entire family of umbilical cord mesenchymal stem cells – to which JadiCell belongs – for the treatment of COPD2, as well as means of selecting cells with increased potency3. This groundbreaking research holds the potential to revolutionize COPD treatment, and could offer hope to people living with the condition.

Today’s exciting discovery is a major milestone in the fight against COPD, adding to our expanding intellectual property portfolio and furthering scientific understanding of this debilitating condition. We are delighted to be able to contribute to the progress towards a potential cure and are hopeful that this knowledge will lead to a brighter future for those suffering from this illness. At Aileron Therapeutics, we are committed to finding a cure for COPD and are optimistic that this discovery is yet another step on the path towards that goal.

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is dedicated to revolutionizing healthcare through immune modulation, with a goal of providing treatments and potential cures for a range of diseases. Our team of experts is working hard to develop therapies that will revolutionize the way we treat and manage diseases. By leveraging the power of the immune system, we are aiming to make a lasting impact on medical treatments and improve quality of life for those affected by disease.

Leave a Comment